Skip to main content
Clinical Trials/KCT0002721
KCT0002721
Not yet recruiting
未知

The Effect of tDCS on Cognitive Function among MCI Patients: a randomized, double blind study

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
20
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Adults with the age of 60 or more, but less than 80 (based on resident registration number)
  • 2\) Those with subjective memory impairment while maintaining normal general functions and daily life performance
  • 3\) Declined cognitive function suggested by Korean Version of the Mini–Mental State Examination for Dementia Screening(MMSE\-DS)
  • 4\) Seoul\-Instrumental Activities of Daily living score 7 or below
  • 5\) Korean version of Global Deterioration Scale (GDS) score of 2\~3 or Clinical Dementia Rating(CDR) score of 0\.5 assessed by the clinician
  • 6\) Korean version of Geriatric depression scale(K\-GDS) score 8 or below

Exclusion Criteria

  • 1\) A person who was diagnosed with the Alzheimer's disease or is currently taking cognitive enhancer such as donepezil, rivastigmine, galantamine, or memantine
  • 2\) History of intellectual disability
  • 3\) Medical history that can cause cognitive dysfunction
  • 4\) A person who is currently diagnosed with alcohol dependence using Diagnostic and Statistical Manual of Mental Disorders 4th edition(DSM\-IV)
  • 5\) History of seizure
  • 6\) A person who suffers from serious dysfunction in cardiovascular, digestive, respiratory, endocrine or central nervous systems
  • 7\) A person who received cerebrovascular surgery including brain and carotid artery
  • 8\) A person who seems to have a problem with attaching the electrodes due to scalp deformity, inflammatory reaction, or other dermatological reasons
  • 9\) A person who is prohibited from applying transcranial direct current stimulation device with other reasons such as a metal plate inserted in cephalic region
  • 10\) A person who participated in other clinical trials within 30 days from screening

Outcomes

Primary Outcomes

Not specified

Similar Trials